Showing results (1851-1860 of 2,791) with videos related to
Sort By:
Pageof 280
Drugs & Aging|September 28, 2007
Individualising therapy for older adults with diabetes mellitusDanelle Cayea, Cynthia Boyd, Samuel C DursoDrugs & Aging|September 28, 2007
Meta-analysis of randomised trials comparing gemcitabine-based doublets versus gemcitabine alone in patients with advanced and metastatic pancreatic cancerEugeniu Banu, Adela Banu, Andrei Fodor, et al.Drugs & Aging|June 28, 2008
Thromboprophylaxis in elderly patients undergoing major orthopaedic surgeryClifford W Colwell, Mary E HardwickDrugs & Aging|June 28, 2008
Evaluation of adverse events of oral antihyperglycemic monotherapy experienced by a geriatric population in a real-world setting: a retrospective cohort analysisCarl V Asche, Carrie McAdam-Marx, Laura Shane-McWhorter, et al.Drugs & Aging|November 21, 2007
Drug treatment of chronic heart failure in the elderlyGregor Leibundgut, Matthias Pfisterer, Hans-Peter Brunner-La RoccaDrugs & Aging|November 22, 2008
Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patientRobert W Johnson, Gunnar Wasner, Patricia Saddier, et al.Drugs & Aging|November 22, 2008
Medication withdrawal trials in people aged 65 years and older: a systematic reviewShoba Iyer, Vasi Naganathan, Andrew J McLachlan, et al.Drugs & Aging|April 11, 2009
Physical and mental fatigue in Parkinson's disease: epidemiology, pathophysiology and treatmentJau-Shin LouDrugs & Aging|April 11, 2009
Value of a new fixed-combination pack of bisphosphonate, calcium and vitamin D in the therapy of osteoporosis: results of two quantitative patient research studiesJohann D Ringe, Patrice Fardellone, Hans-Peter Kruse, et al.Drugs & Aging|February 18, 2009
Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trialThijs H A M Vinks, Toine C G Egberts, Ton M de Lange, et al.Pageof 280